search
Back to results

Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl (NOLFentanyl)

Primary Purpose

Pain, Postoperative, Opioid Use, Nociceptive Pain

Status
Completed
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
fentanyl NOL guided
Sponsored by
Victor Contreras, MSN
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pain, Postoperative focused on measuring pain, Postoperative Pain, fentanyl, Nociceptive monitoring index

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA I-II
  • Elective abdominal surgery without a neuraxial block.
  • Over 2 horas.
  • Body Mass Index 18 - 30 kg/m2

Exclusion Criteria:

  • Cardiac surgery
  • Cardiopathy
  • Arrhythmia or use of pacemakers.
  • Chronic Kidney disease (Plasma Crea >1 mg/dL).
  • Allergic to drugs of this study.
  • Opioids or Non-inflammatory drugs over 5 days for two weeks before surgery.
  • Neuropathies and dysautonomias.
  • Beta-blockers and other drugs that act at the level of the sympathetic system the month prior to surgery.
  • Chemotherapy.

Sites / Locations

  • Victor Contreras

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

fentanyl NOL guided

fentanyl standard analgesia

Arm Description

A bolus of 2 mcg/kg IV Fentanyl will be given at the induction of the anesthesia. A bolus of 0,5 - 1 mcg/kg IV Fentanyl will be given at the time of incision and during surgery following a predeterminate NOL index + heart rate + mean arterial blood pressure variations.

A bolus of 2 mcg/kg IV Fentanyl will be given at the induction of the anesthesia. A bolus of 0,5 - 1 mcg/kg IV Fentanyl will be given at the time of incision and during surgery following the heart rate and mean arterial blood pressure variations.

Outcomes

Primary Outcome Measures

Consumption of IV fentanyl intra-operative in the NOL-guided group compared to the standard group.
Total consumption of fentanyl in mcg.
Consumption of opioid in the early postoperative in the NOL-guided group compared to the standard group.
Total consumption of morphine in mg.

Secondary Outcome Measures

Pain measured by Visual Analog Scale (VAS) in the NOL-guided group compared to the standard group.
Visual Analog Scale 0 to 10. 0 = no pain. 10 = worse pain Values to find out is less than 5-6
Sensorial thresholds in the NOL-guided group compared to the standard group.
QST (Quantitative Sensory Testing) is a valuable method for diagnosing peripheral nervous system disorders. Thermal Testing Mechanical test threshold Mechanical pain threshold Wind-up phenomenon Vibration detection threshold Pressure pain threshold
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Inflammatory markers in the NOL-guided group compared to the standard group.
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Inflammatory markers in the NOL-guided group compared to the standard group.
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Inflammatory markers in the NOL-guided group compared to the standard group.
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Persistent pain at three months in the NOL-guided group compared to the standard group.
Brief Pain Inventory by telephone call

Full Information

First Posted
February 27, 2019
Last Updated
March 7, 2022
Sponsor
Victor Contreras, MSN
search

1. Study Identification

Unique Protocol Identification Number
NCT03858621
Brief Title
Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl
Acronym
NOLFentanyl
Official Title
Comparison of Postoperative Nociception Outcomes Between NOL - Guided and Standard Intraoperative Analgesia Based on Fentanyl in Patients Undergoing Elective Surgery With General Anesthesia
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
March 15, 2019 (Actual)
Primary Completion Date
February 23, 2022 (Actual)
Study Completion Date
February 23, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Victor Contreras, MSN

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Pain is defined as an unpleasant sensory and emotional conscious experience, associated with actual or potential tissue damage. Nociception is the sympathetic response to noxious stimuli during unconsciousness. The appearance of different forms of chronic pain results from sensitization of both peripheral and central neural circuits of pain, which involves inflammatory mechanisms both at a systemic level and specifically in the peripheric and central nervous system, as observed through elevation of specific neuroinflammatory mediators, such as MCP-1, IL-1, IL-1b, and IL-10. Clinically, this sensitization expresses as hyperalgesia and allodynia, which increase postoperative pain and morbidity, but also induce permanent modifications in the nociceptive system. These effects may be ameliorated by adequately adjusting intraoperative analgesia through use of nociception/analgesia balance monitors, of which Nociception Level Index (NOL) shows convenient characteristics and promising results from previous studies. Objectives: The goal of our study is to assess the utility of NOL index monitoring against standard care for Fentanyl-based analgesia by measuring postoperative pain, sensorial thresholds and inflammatory markers related to nociception. Hypothesis: The use of NOL index to guide the intraoperative analgesia will produce less postoperative pain, hyperalgesia, allodynia, and neuroinflammation.
Detailed Description
Methodology: In this RCT double-blinded study will invite to 100 patients aged between 18 and 50 years admitted for elective surgery that is planned to require general anesthesia, with fentanyl as the opioid of choice for intraoperative analgesia. Each patient will be randomly allocated to one of two groups: the intervention group will be provided intraoperative analgesia guided by NOL values (n=50), and the control group will be provided standard intraoperative analgesia (n=50). To account for inter-personal variability, the NOL threshold value associated with nociceptive stimulation will be assessed on each patient at baseline condition with the Quantitative Sensory Testing (QST) and neuroinflammatory mediators MCP-1, IL-1, IL-1b, and IL-10 will be measured pre- and post-surgery in both groups. Opioid consumption and AVS will be assessed during the stay at the post-surgical care unit as a measurement of post-operative pain and will follow them until three months after surgery. Statistical Analysis: Results will be expressed as means (±SD) or numbers (%). When indicated, 95% confidence interval (CI) will be calculated. A p-value < 0.05 will be considered statistically significant. Differences between groups on post-surgical opioid consumption, Δz-score of QST measurements, and serum biomarkers level will be analyzed with Student's T-test for unpaired samples. For analysis purposes, VAS scores will be grouped into three distinct categories: Mild (0-3), Moderate (4-6) and Severe (7-10) pain. Differences between groups will be analyzed with Chi-square test.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Opioid Use, Nociceptive Pain, Postoperative Pain, Anesthesia, Allodynia, Analgesics, Opioid
Keywords
pain, Postoperative Pain, fentanyl, Nociceptive monitoring index

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 groups of patients. Randomization into group fentanyl NOL-guided vs fentanyl standard according to randomization list for a total number of 100 patients.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Randomization into group fentanyl NOL-guided vs fentanyl standard will be done prior to the entrance in the OR, the day of the surgery.
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
fentanyl NOL guided
Arm Type
Experimental
Arm Description
A bolus of 2 mcg/kg IV Fentanyl will be given at the induction of the anesthesia. A bolus of 0,5 - 1 mcg/kg IV Fentanyl will be given at the time of incision and during surgery following a predeterminate NOL index + heart rate + mean arterial blood pressure variations.
Arm Title
fentanyl standard analgesia
Arm Type
No Intervention
Arm Description
A bolus of 2 mcg/kg IV Fentanyl will be given at the induction of the anesthesia. A bolus of 0,5 - 1 mcg/kg IV Fentanyl will be given at the time of incision and during surgery following the heart rate and mean arterial blood pressure variations.
Intervention Type
Drug
Intervention Name(s)
fentanyl NOL guided
Other Intervention Name(s)
NOL analgesia guided fentanyl administration
Intervention Description
Intervention is NOL monitoring in this group that will help to guide intravenous administration of fentanyl during surgery.
Primary Outcome Measure Information:
Title
Consumption of IV fentanyl intra-operative in the NOL-guided group compared to the standard group.
Description
Total consumption of fentanyl in mcg.
Time Frame
Intra-operative
Title
Consumption of opioid in the early postoperative in the NOL-guided group compared to the standard group.
Description
Total consumption of morphine in mg.
Time Frame
Postoperative Unit (2 hours)
Secondary Outcome Measure Information:
Title
Pain measured by Visual Analog Scale (VAS) in the NOL-guided group compared to the standard group.
Description
Visual Analog Scale 0 to 10. 0 = no pain. 10 = worse pain Values to find out is less than 5-6
Time Frame
Postoperative Unit (Every 30 minutes per 2 hours)
Title
Sensorial thresholds in the NOL-guided group compared to the standard group.
Description
QST (Quantitative Sensory Testing) is a valuable method for diagnosing peripheral nervous system disorders. Thermal Testing Mechanical test threshold Mechanical pain threshold Wind-up phenomenon Vibration detection threshold Pressure pain threshold
Time Frame
Postoperative Unit (2 hours)
Title
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Description
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Time Frame
Postoperative Unit (2 hours)
Title
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Description
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Time Frame
Postoperative (6 hours)
Title
Pain Management Satisfaction in the NOL-guided group compared to the standard group.
Description
Pain Management Satisfaction Scale 1 to 5. 1 = Not satisfied at all. 5 = Completly satisfied One question
Time Frame
Postoperative (12 hours)
Title
Inflammatory markers in the NOL-guided group compared to the standard group.
Description
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Time Frame
Postoperative (0 hours)
Title
Inflammatory markers in the NOL-guided group compared to the standard group.
Description
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Time Frame
Postoperative (6 hours)
Title
Inflammatory markers in the NOL-guided group compared to the standard group.
Description
Concentration in plasma of: MCP1 (pg/mL) , IL6 (pg/mL) , IL1b (pg/mL), IL10 (pg/mL)
Time Frame
Postoperative (12 hours)
Title
Persistent pain at three months in the NOL-guided group compared to the standard group.
Description
Brief Pain Inventory by telephone call
Time Frame
3 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA I-II Elective abdominal surgery without a neuraxial block. Over 2 horas. Body Mass Index 18 - 30 kg/m2 Exclusion Criteria: Cardiac surgery Cardiopathy Arrhythmia or use of pacemakers. Chronic Kidney disease (Plasma Crea >1 mg/dL). Allergic to drugs of this study. Opioids or Non-inflammatory drugs over 5 days for two weeks before surgery. Neuropathies and dysautonomias. Beta-blockers and other drugs that act at the level of the sympathetic system the month prior to surgery. Chemotherapy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
VICTOR CONTRERAS, MSN
Organizational Affiliation
Research Profesor
Official's Role
Study Director
Facility Information:
Facility Name
Victor Contreras
City
Santiago
State/Province
Región Metropolitana
ZIP/Postal Code
8420525
Country
Chile

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21620344
Citation
Gandhi K, Heitz JW, Viscusi ER. Challenges in acute pain management. Anesthesiol Clin. 2011 Jun;29(2):291-309. doi: 10.1016/j.anclin.2011.04.009.
Results Reference
result
PubMed Identifier
26247858
Citation
Baliki MN, Apkarian AV. Nociception, Pain, Negative Moods, and Behavior Selection. Neuron. 2015 Aug 5;87(3):474-91. doi: 10.1016/j.neuron.2015.06.005.
Results Reference
result
PubMed Identifier
19402781
Citation
Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother. 2009 May;9(5):723-44. doi: 10.1586/ern.09.20.
Results Reference
result
PubMed Identifier
23945010
Citation
Argoff CE. Recent management advances in acute postoperative pain. Pain Pract. 2014 Jun;14(5):477-87. doi: 10.1111/papr.12108. Epub 2013 Aug 15.
Results Reference
result

Learn more about this trial

Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl

We'll reach out to this number within 24 hrs